Influence of cigarette smoking on melatonin levels in man

European Journal of Clinical Pharmacology

Volumn 61, Issue 3, 2005, Pages 197-201

  Ursing, Carina ^a   Von Bahr, Christer ^a   Brismar, Kerstin ^b   Röjdmark, Sven ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytochrome p 450(CYP)1A2; Drug metabolism; Melatonin; Smoking

Indexed keywords

MELATONIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; AREA UNDER CURVE; CIRCADIAN RHYTHM; COTININE; FEMALE; HUMANS; MALE; MELATONIN; SMOKING; SMOKING CESSATION;

EID: 20044396960     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0908-7     Document Type: Article

References (24)

1. Alvan G, Piafsky K, Lind M, von Bahr C (1977) Effect of pentobarbital on the disposition of alprenolol. Clin Pharmacol Ther 22:316-321
2. von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Röjdmark S (2000) Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol 56:123-127
3. Benowitz NL (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188-204
4. Benowitz NL, Jacob P 3rd (2000) Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther 67:653-659
5. Carrillo JA, Christensen M, Ramos SI, Alm C, Dahl ML, Benitez J, Bertilsson L (2000) Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 22:409-417
6. Caubet MS, Laplante A, Caille J, Brazier JL (2002) [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake. Isotopes Environ Health Stud 38:71-77
7. Faber MS, Fuhr U (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76:178-184
8. Facciola G, Hidestrand M, von Bahr C, Tybring G (2001) Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur J Clin Pharmacol 56:881-888
9. Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH (1995) Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 33:311-314
10. Grygiel JJ, Birkett DJ (1981) Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther 30:491-496
11. Härtter S, Ursing C, Morita S, Tybring G, von Bahr C, Christensen M, Röjdmark S, Bertilsson L (2001) Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin Pharmacol Ther 70:10-16
12. Kall MA, Clausen J (1995) Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man. Hum Exp Toxicol 14:801-807
13. Molander L, Lunell E, Andersson SB, Kuylenstierna F (1996) Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler. Clin Pharmacol Ther 59:394-400
14. Muranaka H, Higashi E, Itani S, Shimizu Y (1988) Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin, and expired carbon monoxide as biochemical tobacco smoke uptake parameters. Int Arch Occup Environ Health 60:37-41
15. Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162
16. Rowland M (1972) Influence of route of administration on drug availability. J Pharm Sci 61:70-74
17. Schein JR (1995) Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29:1139-1148
18. Schrenk D, Brockmeier D, Morike K, Bock KW, Eichelbaum M (1998) A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol 53:361-367
19. Tarquini B, Perfetto F, Poli R, Tarquini R (1994) Daytime circulating melatonin levels in smokers. Tumori 80:229-232
20. Ursing C, Wikner J, Brismar K, Röjdmark S (2003) Caffeine raises the serum melatonin level in healthy subjects - an indication of melatonin metabolism by cytochrome P450 (CYP) 1A2. J Endocrinol Invest 26:403-406
21. Walle T, Walle UK, Cowart TD, Conradi EC, Gaffrey TE (1987) Selective induction of propranolol metabolism by smoking: additional effects of renal clearance of metabolites. J Pharmacol Exp Ther 241:928-933
22. Wei C, Caccavale RJ, Kehoe JJ, Thomas PE, Iba MM (2001) CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett 171:113-120
23. Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36:425-438
24. Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL (1995) Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 57:552-558